| For: | An Y, Gao S, Zhao WC, Qiu BA, Xia NX, Zhang PJ, Fan ZP. Transforming growth factor-β and peripheral regulatory cells are negatively correlated with the overall survival of hepatocellular carcinoma. World J Gastroenterol 2018; 24(25): 2733-2740 [PMID: 29991878 DOI: 10.3748/wjg.v24.i25.2733] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v24/i25/2733.htm |
| Number | Citing Articles |
| 1 |
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal Cancers. Translational Oncology 2019; 12(3) doi: 10.1016/j.tranon.2018.11.010
|
| 2 |
Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer, Laurence Zitvogel. The immuno-oncological challenge of COVID-19. Nature Cancer 2020; 1(10) doi: 10.1038/s43018-020-00122-3
|
| 3 |
Ishwar Navin, Michael T. Lam, Robin Parihar. Design and Implementation of NK Cell-Based Immunotherapy to Overcome the Solid Tumor Microenvironment. Cancers 2020; 12(12) doi: 10.3390/cancers12123871
|
| 4 |
Yi-Ru Chen, Su-Shan Ouyang, Yan-Ling Chen, Ping Li, Hui-Wen Xu, Sen-Lin Zhu. BRD4/8/9 are prognostic biomarkers and associated with immune infiltrates in hepatocellular carcinoma. Aging 2020; 12(17) doi: 10.18632/aging.103768
|
| 5 |
Ran Yu, Linbo Jin, Fangfang Li, Manabu Fujimoto, Qiang Wei, Zhenhua Lin, Xiangshan Ren, Quanxin Jin, Honghua Li, Fanping Meng, Guihua Jin. Dihydroartemisinin inhibits melanoma by regulating CTL/Treg anti-tumor immunity and STAT3-mediated apoptosis via IL-10 dependent manner. Journal of Dermatological Science 2020; 99(3) doi: 10.1016/j.jdermsci.2020.08.001
|
| 6 |
Xiu Chen, Liqiu Kou, Xiaolu Xie, Song Su, Jun Li, Yaling Li. Prognostic biomarkers associated with immune checkpoint inhibitors in hepatocellular carcinoma. Immunology 2024; 172(1) doi: 10.1111/imm.13751
|
| 7 |
Federico Costante, Leonardo Stella, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Tarik Asselah, Francesca Romana Ponziani. Molecular and Clinical Features of Hepatocellular Carcinoma in Patients with HBV-HDV Infection. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S384751
|
| 8 |
Li Wu, Fu-Rong Yang, Mu-Lan Xing, Sheng-Feng Lu, Hong-Lin Chen, Qiao-Wei Yang, Yu-Ting Zhang, Yin Lu, Yan Huang. Multi-material basis and multi-mechanisms of the Dahuang Zhechong pill for regulating Treg/Th1 balance in hepatocellular carcinoma. Phytomedicine 2022; 100 doi: 10.1016/j.phymed.2022.154055
|
| 9 |
Aswathy R Devan, Keechilat Pavithran, Bhagyalakshmi Nair, Maneesha Murali, Lekshmi R Nath. Deciphering the role of transforming growth factor-beta 1 as a diagnostic-prognostic-therapeutic candidate against hepatocellular carcinoma. World Journal of Gastroenterology 2022; 28(36): 5250-5264 doi: 10.3748/wjg.v28.i36.5250
|
| 10 |
Wen-Han Chang, Drashya Shah, Scott Myers, Michael Potts, Sanjive Qazi, Vuong Trieu. Comparative Tumor Microenvironment Analysis for HCC and PDAC Using KMplotter. International Journal of Molecular Sciences 2025; 26(24) doi: 10.3390/ijms262411920
|
| 11 |
Caecilia H C Sukowati, Korri Elvanita El-Khobar, Claudio Tiribelli. Immunotherapy against programmed death-1/programmed death ligand 1 in hepatocellular carcinoma: Importance of molecular variations, cellular heterogeneity, and cancer stem cells. World Journal of Stem Cells 2021; 13(7): 795-824 doi: 10.4252/wjsc.v13.i7.795
|
| 12 |
Muhammad Wasif Saif, Wen-Han Chang, Scott Myers, Michael Potts, Sanjive Qazi, Vuong Trieu. TGFB2 Expression and Methylation Predict Overall Survival in Pancreatic Ductal Adenocarcinoma Patients. International Journal of Molecular Sciences 2025; 26(13) doi: 10.3390/ijms26136357
|
| 13 |
Jijie Shao, Jintong Na, Honghua Huang, Lei Xiao, Fengqiu Dang, Rongshun Zheng, Liping Zhong, Yongxiang Zhao. The Role of CD4+ T Helper Cell Subsets in Hepatocellular Carcinoma: Implications for Tumour Progression and Immunotherapy. Cells 2026; 15(4) doi: 10.3390/cells15040350
|
| 14 |
Qi Zhang, Qihan Fu, Yinan Shen, Wanyue Cao, Gaowei Jin, Yize Zhang, Jiangchao Wu, Cao Chen, Hongkan Wang, Xingyuan Xu, Ke Sun, Xing Xue, Attilio Bondanza, Daisy Cao, Nina Chu, Nick Durham, Mark Cobbold, Benedetto Farsaci, Maria Letizia Giardino Torchia, Yixin Hao, Yi Hong, Jiaqi Huang, Michael Humphries, Qijie Jian, Gordon Moody, John Stone, Lingyan Sun, Eric Tu, Fei Wang, Fuzhe Wang, Ye Yang, Yihong Yao, Andy Zou, Xueli Bai, Tingbo Liang. GPC3-specific dnTGFβRII-armoured CAR T cells for hepatocellular carcinoma. Nature 2026; doi: 10.1038/s41586-026-10786-z
|
| 15 |
Christine Ménétrier-Caux, Isabelle Ray-Coquard, Jean-Yves Blay, Christophe Caux. Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?. Journal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0549-5
|
| 16 |
David J. Pinato, Nadia Guerra, Petros Fessas, Ravindhi Murphy, Takashi Mineo, Francesco A. Mauri, Sujit K. Mukherjee, Mark Thursz, Ching Ngar Wong, Rohini Sharma, Lorenza Rimassa. Immune-based therapies for hepatocellular carcinoma. Oncogene 2020; 39(18) doi: 10.1038/s41388-020-1249-9
|
| 17 |
Kendi Nishino Miyamoto, Diego Bonatto. Circulating cells and exosomes in acute myelogenous leukemia and their role in disease progression and survival. Clinical Immunology 2020; 217 doi: 10.1016/j.clim.2020.108489
|